S. Krishnamurthi

发表

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Ahmed Kamel, Howard S Hochster, Christopher G Willett, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

R. Schilsky, T. Hensing, P. Ganz, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study

K. Herrmann, S. Partovi, C. Delaney, 2015, Abdominal Imaging.

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine

M. Schluchter, B. Overmoyer, E. Zuhowski, 2009, Cancer Chemotherapy and Pharmacology.

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Small Bowel Adenocarcinoma, Version 1.2020

J. Meyerhardt, A. Benson, C. Willett, 2019 .

Adjuvant therapy for rectal cancer.

T. Kinsella, S. Krishnamurthi, Yuji Seo, 2007, Clinics in colon and rectal surgery.

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment

M. Fakih, T. George, M. Saif, 2021, Cancer Chemotherapy and Pharmacology.

A Multicenter Phase II Study of “Adjuvant” Irinotecan Following Resection of Colorectal Hepatic Metastases

G. Pond, H. Mackay, S. Gallinger, 2005, American journal of clinical oncology.

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.

Manuel Hidalgo, Xin Huang, Shujian Wu, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology.

J. Meyerhardt, C. Willett, Yi-Jen Chen, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Deep hybrid convolutional wavelet networks: application to predicting response to chemoradiation in rectal cancers via MRI

D. Líška, S. Krishnamurthi, S. Viswanath, 2022, Medical Imaging.

Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors

N. Sharma, J. Pink, P. Fu, 2020, Investigational new drugs.

Phase I trial of pomalidomide given for patients with advanced solid tumors

M. Cooney, R. Dreicer, A. Dowlati, 2012, Cancer Chemotherapy and Pharmacology.

Videoconference Intervention for Distance Caregivers of Patients With Cancer: A Randomized Controlled Trial.

S. Douglas, S. Krishnamurthi, P. Mazanec, 2021, JCO oncology practice.

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

J. Meyerhardt, C. Willett, Yi-Jen Chen, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)

J. Meyerhardt, A. Shields, D. Niedzwiecki, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study

M. Talamonti, M. Mulcahy, W. Small, 2012, Journal of Gastrointestinal Surgery.

A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors

J. Lunceford, P. LoRusso, A. Lockhart, 2016, Investigational New Drugs.

Random assignment multicenter phase II study of modified docetaxel, cisplatin, fluorouracil (mDCF) versus DCF with growth factor support (GCSF) in metastatic gastroesophageal adenocarcinoma (GE).

Y. Janjigian, M. Capanu, M. Kemeny, 2010 .

Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study.

Yong Cheng, S. Steele, P. Ding, 2022, European journal of cancer.

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

J. Meyerhardt, James D. Murphy, C. Willett, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study

P. LoRusso, S. Remick, F. Fox, 2014, Investigational New Drugs.

A phase 1–2 clinical study of a second generation oral MEK inhibitor, PD 0325901 in patients with advanced cancer

P. LoRusso, M. Meyer, S. Krishnamurthi, 2005 .

Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702

J. Meyerhardt, R. Goldberg, A. Shields, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation and management of incidental thyroid nodules in patients with another primary malignancy.

S. Krishnamurthi, H. Reynolds, S. Wilhelm, 2007, Surgery.

Pharmacokinetics (PK) and pharmacodynamics (PD) of PD 0325901, a second generation MEK inhibitor after multiple oral doses of PD 0325901 to advanced cancer patients

M. Meyer, S. Krishnamurthi, L. Nabell, 2005 .

NCCN Guidelines Insights: Colon Cancer, Version 2.2018.

J. Meyerhardt, James D. Murphy, C. Willett, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Metastatic Pancreatic Cancer: ASCO Guideline Update.

T. Conroy, P. Philip, M. Shah, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Guidelines Insights: Rectal Cancer, Version 6.2020.

J. Meyerhardt, C. Willett, Yi-Jen Chen, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.

P. LoRusso, M. Saif, A. Lockhart, 2010 .

5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers

Yiqing Zhao, S. Markowitz, J. Barnholtz-Sloan, 2020, Cancer Research.

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Ahmed Kamel, Howard S Hochster, Christopher G Willett, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

A Blueprint to Advance Colorectal Cancer Immunotherapies

Vanessa M. Hubbard-Lucey, L. Diaz, E. Jaffee, 2017, Cancer Immunology Research.

NCCN Rectal Cancer , Version 2 . 2018 Clinical Practice Guidelines in Oncology

J. Meyerhardt, James D. Murphy, C. Willett, 2018 .

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers

Patricia M. LoRusso, Weiwei Tan, K. Wilner, 2010, Clinical Cancer Research.

A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer.

A. Khorana, J. Pink, Y. Saunthararajah, 2020, American journal of cancer research.

Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.

J. Wright, P. Fu, A. Dowlati, 2013, The oncologist.

Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors

M. Cooney, A. Dowlati, S. Remick, 2009, Investigational New Drugs.

Phase 1 study of weekly anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody IMC-18F1 in patients with advanced solid malignancies

P. LoRusso, E. Rowinsky, F. Fox, 2008 .

Phase I trial of daily lenalidomide and docetaxel given every three weeks in patients with advanced solid tumors

M. Cooney, S. Remick, S. Krishnamurthi, 2007 .

Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation

P. Philip, E. Chen, S. Krishnamurthi, 2021, JCO oncology practice.

A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma

W. Bshara, R. Bies, K. Attwood, 2020, British Journal of Cancer.

Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors

M. Borad, A. Daud, W. Messersmith, 2011, Clinical Cancer Research.

FG-3019, A Human Monoclonal Antibody to Connective Tissue Growth Factor, Combined with Chemotherapy in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

A. Koong, S. Hemmerich, A. Giaccia, 2016 .

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma

M. Schluchter, A. Dowlati, S. Remick, 2009, Cancer Chemotherapy and Pharmacology.

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.

A. Khorana, P. Philip, M. Shah, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.

M. Shah, Y. Janjigian, M. Capanu, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019).

Yi Wang, J. Oh, A. Benson, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients

G. Cooper, A. Rimm, P. Fu, 2014, PloS one.

Understanding Multilevel Factors Related to Urban Community Trust in Healthcare and Research

S. Krishnamurthi, Monica Webb Hooper, Charlene Mitchell, 2019, International journal of environmental research and public health.

Anal Carcinoma , Version 2 . 2018 Clinical Practice Guidelines in Oncology

J. Meyerhardt, A. Benson, James D. Murphy, 2018 .

Racial disparities negatively impact outcomes in early‐onset colorectal cancer independent of socioeconomic status

A. Khorana, D. Líška, S. Krishnamurthi, 2021, Cancer medicine.

Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study.

A. Rosemurgy, D. Wagener, S. Krishnamurthi, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

A pilot clinical trial of p53/p16-independent epigenetic therapy for pancreatic ductal adenocarcinoma (PDA).

A. Khorana, Y. Saunthararajah, S. Krishnamurthi, 2020 .

Comparison of characteristics and outcomes of young‐onset versus average onset pancreatico‐biliary adenocarcinoma

A. Khorana, S. Krishnamurthi, B. Estfan, 2023, Cancer medicine.

Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

J. Meyerhardt, A. Benson, C. Willett, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Recent Clinical Advances in Rare Gastrointestinal Tumors

B. Laderian, S. Krishnamurthi, Suneel D. Kamath, 2023, Advances in Oncology.

Bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor: Preliminary results from a phase 1 study in patients with advanced malignant solid tumors

A. Daud, W. Messersmith, S. Krishnamurthi, 2007 .

Association between physical activity and the time course of cancer recurrence in stage III colon cancer

J. Meyerhardt, A. Shields, D. Niedzwiecki, 2023, British Journal of Sports Medicine.

A pilot study of a low glycemic load diet in patients with stage I-III colorectal cancer.

N. Berger, N. Meropol, S. Krishnamurthi, 2021, Journal of gastrointestinal oncology.

Phase I clinical trial of the glutaminase inhibitor CB-839 plus capecitabine in patients with advanced solid tumors.

S. Markowitz, J. Barnholtz-Sloan, N. Meropol, 2018 .

Limb Salvage by Custom Prosthesis: Madras Experience

S. Krishnamurthi, V. Shantha, M. Natarajan, 1992 .

Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer.

J. Meyerhardt, P. Philip, A. Shields, 2023, JAMA oncology.

Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance)

J. Meyerhardt, A. Shields, S. Krishnamurthi, 2023, British Journal of Cancer.

Clinical aspects of a phase I study of PD-0325901, a selective oral MEK inhibitor, in patients with advanced cancer

K. Wilner, P. LoRusso, P. Chapman, 2007 .

Pharmacokinetic (PK) and pharmacodynamic (PD) results of a phase I study of PD-0325901, a second generation oral MEK inhibitor, in patients with advanced cancer

Weiwei Tan, K. Wilner, P. LoRusso, 2007 .

Comparative endoscopic study of primary gastric lymphoma vs. gastric carcinoma

S. Krishnamurthi, V. Swaroop, A. Nagral, 1994, Journal of surgical oncology.

Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers

A. Chak, C. Hoppel, P. Fu, 2009, Cancer Chemotherapy and Pharmacology.

Racial disparities negatively impact outcomes for patients with early-onset colorectal cancer independent of income or education status.

A. Khorana, D. Líška, S. Krishnamurthi, 2021 .

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer

G. Ku, M. Fakih, S. Krishnamurthi, 2023, Journal for ImmunoTherapy of Cancer.

Integrating multi-plane and multi-region radiomic features to predict pathologic response to neoadjuvant chemoradiation in rectal cancers via pre-treatment MRI

D. Líška, S. Krishnamurthi, S. Viswanath, 2023, Medical Imaging.

Toxicity and outcome data in a phase II study of weekly docetaxel in combination with erlotinib in recurrent and/or metastatic breast cancer (MBC).

B. Overmoyer, P. Fu, S. Remick, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pancreatic metastases to the colon: an unusual cause of colonic obstruction

S. Krishnamurthi, E. Downs-Kelly, P. Chahal, 2019, BMJ Case Reports.

Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.

M. Fakih, B. Carneiro, B. Lembersky, 2012, Clinical colorectal cancer.

Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.

J. Meyerhardt, C. Willett, C. Sofocleous, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Colon Cancer , Version 2 . 2018 Featured Updates to the NCCN Guidelines

J. Meyerhardt, James D. Murphy, C. Willett, 2018 .

Liquid Biopsy by ctDNA in Liver Transplantation for Colorectal Cancer Liver Metastasis

K. Sasaki, F. Aucejo, S. Krishnamurthi, 2023, Journal of Gastrointestinal Surgery.

A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors

M. Cooney, A. Dowlati, S. Remick, 2011, Investigational New Drugs.

Immunotherapy for Advanced Hepatocellular Carcinoma-a Large Tertiary Center Experience

F. Aucejo, S. Krishnamurthi, B. Estfan, 2023, Journal of Gastrointestinal Surgery.

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors

M. Cooney, A. Dowlati, N. Meropol, 2012, Cancer Chemotherapy and Pharmacology.

FG-3019, a human monoclonal antibody to CTGF, with gemcitabine/erlotinib in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma.

A. Koong, A. Giaccia, C. Lopez, 2013 .

Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)

J. Meyerhardt, R. Goldberg, A. Shields, 2023, Cancer.

Phase I trial of daily pomalidomide in patients with advanced solid tumors.

M. Cooney, R. Dreicer, A. Dowlati, 2010 .

Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

M. Mulcahy, J. Skibber, A. Venook, 2024, Journal of the National Comprehensive Cancer Network : JNCCN.